CPRX vs. HYDR
CPRX (Catalyst Pharmaceuticals, Inc.) is a stock, while HYDR (Global X Hydrogen ETF) is Alternative Energy Equities fund tracking the Solactive Global Hydrogen Index - Benchmark TR Net. Over the past 3 years, CPRX returned 33.66%/yr vs 8.05%/yr for HYDR. At a 0.28 correlation, their price movements are largely independent.
Performance
CPRX vs. HYDR - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, CPRX achieves a 34.53% return, which is significantly lower than HYDR's 68.73% return.
CPRX
- 1D
- 0.06%
- 1M
- 0.45%
- YTD
- 34.53%
- 6M
- 29.59%
- 1Y
- 41.95%
- 3Y*
- 33.66%
- 5Y*
- 39.71%
- 10Y*
- 44.45%
HYDR
- 1D
- -5.46%
- 1M
- -24.76%
- YTD
- 68.73%
- 6M
- 61.64%
- 1Y
- 158.69%
- 3Y*
- 8.05%
- 5Y*
- —
- 10Y*
- —
CPRX vs. HYDR - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
CPRX Catalyst Pharmaceuticals, Inc. | 34.53% | 11.84% | 24.15% | -9.62% | 174.74% | 23.09% |
HYDR Global X Hydrogen ETF | 68.73% | 43.73% | -33.08% | -36.49% | -47.24% | -15.79% |
Correlation
The correlation between CPRX and HYDR is 0.18, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.18 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.21 |
Correlation (All Time) Calculated using the full available price history since Jul 14, 2021 | 0.28 |
The correlation between CPRX and HYDR shifts across timeframes, from 0.18 (1 year) to 0.28 (all time), reflecting how their relationship changes across market environments.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
CPRX vs. HYDR — Risk / Return Rank
CPRX
HYDR
CPRX vs. HYDR - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Catalyst Pharmaceuticals, Inc. (CPRX) and Global X Hydrogen ETF (HYDR). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| CPRX | HYDR | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -1.59 | ||
| Sortino ratioReturn per unit of downside risk | -1.45 | ||
| Omega ratioGain probability vs. loss probability | 1.25 | 1.40 | -0.14 |
| Calmar ratioReturn relative to maximum drawdown | 3.03 | 5.37 | -2.33 |
| Martin ratioReturn relative to average drawdown | 7.92 | 11.63 | -3.70 |
Loading charts...
Drawdowns
CPRX vs. HYDR - Drawdown Comparison
The maximum CPRX drawdown since its inception was -94.25%, which is greater than HYDR's maximum drawdown of -89.28%. Use the drawdown chart below to compare losses from any high point for CPRX and HYDR.
Loading charts...
Drawdown Indicators
| CPRX | HYDR | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -94.25% | -89.28% | -4.97% |
Max Drawdown (1Y)Largest decline over 1 year | -13.91% | -29.76% | +15.85% |
Max Drawdown (3Y)Largest decline over 3 years | -27.29% | -70.32% | +43.03% |
Max Drawdown (5Y)Largest decline over 5 years | -45.37% | — | — |
Max Drawdown (10Y)Largest decline over 10 years | -64.87% | — | — |
Current DrawdownCurrent decline from peak | 0.00% | -61.26% | +61.26% |
Average DrawdownAverage peak-to-trough decline | -51.90% | -64.13% | +12.23% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 5.32% | 13.71% | -8.39% |
Volatility
CPRX vs. HYDR - Volatility Comparison
The current volatility for Catalyst Pharmaceuticals, Inc. (CPRX) is 0.46%, while Global X Hydrogen ETF (HYDR) has a volatility of 18.57%. This indicates that CPRX experiences smaller price fluctuations and is considered to be less risky than HYDR based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| CPRX | HYDR | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 0.46% | 18.57% | -18.11% |
Volatility (6M)Calculated over the trailing 6-month period | 22.84% | 38.42% | -15.58% |
Volatility (1Y)Calculated over the trailing 1-year period | 32.65% | 55.43% | -22.78% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 47.79% | 47.51% | +0.28% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 60.09% | 47.51% | +12.58% |
Dividends
CPRX vs. HYDR - Dividend Comparison
CPRX has not paid dividends to shareholders, while HYDR's dividend yield for the trailing twelve months is around 2.26%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
CPRX Catalyst Pharmaceuticals, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
HYDR Global X Hydrogen ETF | 2.26% | 3.82% | 0.40% | 0.00% | 0.00% | 0.06% |
Frequently Asked Questions
CPRX and HYDR have a correlation of 0.18, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
HYDR has higher volatility (18.57%) compared to CPRX (0.46%). In terms of maximum drawdown, CPRX dropped -94.25% vs HYDR's -89.28%.
HYDR currently has the higher Sharpe Ratio (2.88 vs 1.29), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for CPRX and HYDR
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer